Transaction #32136 · Form 4 · 0001231919-26-001433
Wave Life Sciences, Inc. · Stock award · Common Stock
Wave Life Sciences, Inc. · Transacted October 5, 2026 · Filed October 7, 2026
What does this filing report?
An SEC Form 4 filing for Wave Life Sciences, Inc. records a stock award involving Common Stock on October 5, 2026. The reported quantity was 10,700. The filing date is October 7, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Wave Life Sciences, Inc.
- Company CIK
- 0001631574
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 10,700
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 39,515
- Ownership description
- See footnotes
- SEC acceptance time
- Oct 7, 2026, 9:06 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- RA Capital Healthcare Fund LP ↗
Director · 10% owner
CIK 0001315082
- RA CAPITAL MANAGEMENT, L.P. ↗
Director · 10% owner
CIK 0001346824
- Kolchinsky Peter ↗
Director · 10% owner
CIK 0001384859
- Shah Rajeev M. ↗
Director · 10% owner
CIK 0001619841
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Dr. Kolchinsky was granted this restricted stock unit award (RSU) pursuant to the 2026 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Issuer's 2027 annual meeting of stockholders or October 5, 2027.
- F2
- Dr. Kolchinsky is a Managing Partner of the Adviser who serves on the Issuer's board of directors. Under Dr. Kolchinsky's arrangement with the Adviser, Dr. Kolchinsky holds the RSUs and options for the benefit of the Fund. Dr. Kolchinsky is obligated to turn over to the Adviser any net cash or shares received upon settlement of the RSUs, or exercise of the options, as applicable, which will offset advisory fees owed by the Fund to the Adviser.
- F3
- RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- F4
- Held directly by the Fund.
- F5
- Dr. Kolchinsky was granted this option pursuant to the 2026 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Issuer's 2027 annual meeting of stockholders or October 5, 2027.
Remarks
Dr. Peter Kolchinsky, a Managing Partner of the Adviser, serves on the Issuer's board of directors.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.